Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-9 study of TECVAYLI® ...
In TODAY.com's Expert Tip of the Day, a therapist reveals an important healthy habit that too many of us overlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback